12th Annual DPHARM
Meet with Cognivia at DPHARM 2022
Are you going to the DPHARM conference from September 13-14? We’d love to meet with you!
This year’s conference is all about new ideas for clinical trials – and as an innovator of analytical tools to accelerate drug development, we can’t wait to share ours (and hear from other industry pioneers).
Plus, we're a nominated idol for DPHARM Idol Disrupt 2022! Don't miss it!
Join us at DPHAM 2022 by using the code COG20 for 20% off of registration.
Once you’re registered, schedule a time to meet with our team by filling out the form.
Looking forward to connecting!
DPHARM Idol Disrupt 2022
4:40 PM ET on September 13, 2022
Cognivia is honored to be a nominated idol of DPHARM Idol Disrupt – a live show featuring a select group of innovators who present disruptive technologies that could be a changing force for clinical trials. CEO Dominique Demolle will be there to provide an overview of our novel solution, Placebell©™, and answer questions from DPHARM Idol’s panel of judges.
Cognivia is an innovator of analytical tools to optimize and accelerate the clinical development of new medicines. The privately held company was founded in 2013 by longtime colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace. Cognivia helps lessen risk and increase clinical trial success. It can help reduce the variability of study data by 30 percent, which directly translates into increased study power and reduced risk of trial failure. This can further lead to fewer patients needed in a study, equating to less cost and time.
The company offers Placebell, a solution that improved clinical trial assay sensitivity by characterizing and managing the individual placebo response in a variety of disease states where the placebo effect masks the true efficacy of potentially important therapies.